- Home
- ARR vs OMCL Comparison
ARR vs OMCL Comparison
Compare ARR & OMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARR
- OMCL
- Stock Information
- Founded
- ARR 2008
- OMCL 1992
- Country
- ARR United States
- OMCL United States
- Employees
- ARR N/A
- OMCL N/A
- Industry
- ARR Real Estate Investment Trusts
- OMCL Computer Manufacturing
- Sector
- ARR Real Estate
- OMCL Technology
- Exchange
- ARR Nasdaq
- OMCL Nasdaq
- Market Cap
- ARR 1.4B
- OMCL 1.3B
- IPO Year
- ARR N/A
- OMCL 2001
- Fundamental
- Price
- ARR $16.47
- OMCL $28.03
- Analyst Decision
- ARR Hold
- OMCL Buy
- Analyst Count
- ARR 5
- OMCL 6
- Target Price
- ARR $21.00
- OMCL $44.83
- AVG Volume (30 Days)
- ARR 2.0M
- OMCL 550.7K
- Earning Date
- ARR 07-23-2025
- OMCL 07-31-2025
- Dividend Yield
- ARR 17.50%
- OMCL N/A
- EPS Growth
- ARR N/A
- OMCL N/A
- EPS
- ARR N/A
- OMCL 0.45
- Revenue
- ARR $44,778,000.00
- OMCL $1,135,755,000.00
- Revenue This Year
- ARR $532.77
- OMCL $3.84
- Revenue Next Year
- ARR $15.62
- OMCL $4.07
- P/E Ratio
- ARR N/A
- OMCL $61.95
- Revenue Growth
- ARR 41.14
- OMCL 3.00
- 52 Week Low
- ARR $13.18
- OMCL $22.66
- 52 Week High
- ARR $21.93
- OMCL $55.75
- Technical
- Relative Strength Index (RSI)
- ARR 50.17
- OMCL 39.02
- Support Level
- ARR $16.16
- OMCL $30.73
- Resistance Level
- ARR $16.93
- OMCL $32.05
- Average True Range (ATR)
- ARR 0.26
- OMCL 0.76
- MACD
- ARR -0.02
- OMCL -0.26
- Stochastic Oscillator
- ARR 50.53
- OMCL 0.99
About ARR ARMOUR Residential REIT Inc.
ARMOUR Residential REIT Inc operate in the U.S. and invest in fixed rate residential, adjustable rate and hybrid adjustable rate residential MBS issued or guaranteed by U.S. GSEs or guaranteed by Ginnie Mae. It also invest in U.S. Treasury Securities and money market instruments.
About OMCL Omnicell Inc. ($0.001 par value)
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.